Abstract
Background: Invasive fungal infections (IFIs) are primarily caused by Candida spp., Cryptococcus neoformans, Aspergillus spp., Mucor spp., Sporothrix spp., and Pneumocystis spp., which attack human organs with a strong pathogenicity and exhibit drug resistance against commonly used chemical drugs. Therefore, the search for alternative drugs with high efficacy, low resistance rates, few side effects, and synergistic antifungal effects remains a major challenge. The characteristics of natural products with structural and bioactive diversity, lower drug
resistance, and rich resources make them a major focus of the development of antifungal drugs.
Objectives: This review attempts to summarize the origin, structure, and antifungal activity of natural
products and their derivatives with MIC ≤ 20 μg/mL or 100 μM, focusing on their MoA and SAR.
Methods: All pertinent literature databases were searched. The search keywords were antifungal or
antifungals, terpenoids, steroidal saponins, alkaloid, phenols, lignans, flavonoids, quinones, macrolide,
peptide, tetramic acid glycoside, polyene, polyketide, bithiazole, natural product, and derivatives.
All the related literature (covering the past 20 years, 2001-2022) was evaluated.
Results: In total, 340 natural products and 34 synthesized derivatives with antifungal activity from 301 studies were included in this review. These compounds were derived from terrestrial plants, ocean life, and microorganisms and exhibited in vitro and in vivo potent antifungal activity alone or in combination. The MoA and SARs of reported compounds were summarized whenever applicable.
Conclusion: In this review, we attempted to review the available literature on natural antifungal products and their derivatives. Most of the studied compounds showed potent activity against Candida species, Aspergillus species, or Cryptococcus species. Some of the studied compounds also demonstrated the ability to impair the cell membrane and cell wall, inhibit hypha and biofilms, and cause mitochondrial dysfunction. Although the MoAs of these compounds are not well understood yet, they can be used as lead components for the development of new, effective, and safe antifungal agents through their novel mechanisms.
Graphical Abstract
[7]
Food Additives Permitted For Direct Addition To Food For Human Consumption; US Food and Drug Administration: USA, 2022, p. 172.
[30]
Njateng, G.S.S.; Du, Z.; Gatsing, D.; Donfack, A.R.N.; Talla, M.F.; Wabo, H.K.; Tane, P.; Mouokeu, R.S.; Luo, X.; Kuiate, J-R. Antifungal properties of a new terpernoid saponin and other compounds from the stem bark of Polyscias fulva Hiern (Araliaceae). BMC Complement. Altern. Med., 2015, 15, 25-21.
[31]
Iqbal, M.; Bilal, M.; Iqbal, R.; Akram, M.; Baloch, I.B.; Baloch, M.K. New bioactive oleanane type compounds from Coriandrum sativum Linn. J. Chem., 2014, 2014, 396436.
[33]
Polatoglu, K.; Gören, N. Ulubelenolide: A New triterpene lactone from Tanacetum chiliophyllum (Fisch. & Mey.) var. monocephalum Grierson. Rec. Nat. Prod., 2015, 9, 3-2015.
[40]
Chang, W.Q.; Wu, X.Z.; Cheng, A.X.; Zhang, L.; Ji, M.; Lou, H.X. Retigeric acid B exerts antifungal effect through enhanced reactive oxygen species and decreased cAMP. BBA - Gen Subjects, 2011, 1810(5), 569-576.
[45]
Favre-Godal, Q.; Dorsaz, S.; Marcourt, L.; Bertini, V.; Dormia, E.; Michellod, E.; Voinesco, F.; Gupta, M.; Gindro, K.; Sanglard, D.; Queiroz, E.F.; Wolfender, J-L. Identification of triterpenoids from Schefflera systyla, Odontadenia puncticulosa and Conostegia speciosa and in depth investigation of their in vitro and in vivo antifungal activities. J. Braz. Chem. Soc., 2017, 28(3S), 443-454.
[48]
Hu, Q.; Chen, Y-Y.; Jiao, Q-Y.; Khan, A.; Li, F.; Han, D-F.; Cao, G-D.; Lou, H-X. Triterpenoid saponins from the pulp of Sapindus mukorossi and their antifungal activities. Phytochemistry, 2018, 147, 1-8.
[56]
Zhang, J.; Zheng, X.; Cao, Y.; Jun, G.; Jiang, Y. Study on regulation of ERG genes expression in Candida albicans by a new anti-fungi agent TTS-12. Chung Kuo Yao Hsueh Tsa Chih, 2011, 46(16), 1229-1234.
[57]
Inhibitory effects of Tribulus terrestris steroid saponin TTS-12 on building biofilm of Cryptococcus neoformans. Chin J Mycol, 2011, 6(6), 341-343.
[137]
Liu, R.H.; Shang, Z.C.; Li, T.X.; Yang, M.H.; Kong, L.Y. In vitro antibiofilm activity of eucarobustol e against candida albicans. Antimicrob Agents Chemother, 2017, 61(8), AAC.02707-02716.
[149]
Nzogong, R.T.; Ndjateu, F.S.T.; Ekom, S.E.; Fosso, J-A.M.; Awouafack, M.D.; Tene, M.; Tane, P.; Morita, H.; Choudhary, M.I.; Tamokou, J-D-D. Antimicrobial and antioxidant activities of triterpenoid and phenolic derivatives from two Cameroonian Melastomataceae plants: Dissotis senegambiensis and Amphiblemma monticola. BMC Complement. Altern. Med., 2018, 18, 159-151.
[157]
Choi, H.; Lee, J.; Chang, Y.S.; Woo, E.-R.; Lee, D.G. Isolation of (-)-olivil-9′-O-β-d-glucopyranoside from Sambucus williamsii and its antifungal effects with membrane-disruptive action. BBA - Biomembranes, 2013, 1828(8), 2002-2006.
[160]
Leng, P.; Guo, X.; Yang, Y.; Lou, H. Primary study on antifungal activities and reversal of fluconazole resistance of plagiochin E. Chung Kuo Yao Hsueh Tsa Chih, 2007, 42(5), 349-352.
[207]
Zhang, H.; Li, J.; Zhang, J.; Shi, H.; Lin, X.; Sun, H. Purpurin inhibits the adhesion of Candida albicans biofilms. Int. J. Clin. Exp. Med., 2016, 9(6), 10070-10076.